Baylon, Maynard S.
HRN: 12-72-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2023
CEFTRIAXONE 1G (VIAL)
11/13/2023
11/20/2023
IV
2gms
Q24
T/c Uti, R/o Acute Appendicitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes